A worldwide leader in autoimmune disease research
Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus. These are a just a few of more than 80 autoimmune diseases that affect one in 20 Americans and cost an estimated $20 billion a year in medical care.
While many autoimmune diseases are little known, they all have a common cause: The immune system – which is designed to protect the body against infection – attacks the body’s healthy tissue instead.
Benaroya Research Institute at Virginia Mason (BRI), located in Seattle, Washington, is a worldwide leader in autoimmune disease research. BRI’s teams of world-renowned scientists work every day to develop therapies to reverse the effects of autoimmune diseases – and to eliminate them altogether.
Today, these scientists are making great headway in unlocking the mysteries of the immune system and solving the puzzle of autoimmune diseases.
Autoimmune Diseases: Affecting Someone You Know
The diverse array of autoimmune diseases includes illnesses throughout the body, such as:
- The skin (psoriasis)
- Joints and tissue (rheumatoid arthritis, lupus, scleroderma)
- The nervous system (multiple sclerosis)
- Digestive system (ulcerative colitis, Crohn’s disease)
- Endocrine system (Type 1 diabetes, thyroid disease, Addison’s disease)
No tissue or organ is immune from autoimmune diseases. Which is why unlocking the immune system is so important.
BRI’s Clinical Research Studies
BRI has nearly 100 clinical research studies underway every day. The groundbreaking work at BRI would not be possible without contributions from individuals, corporations and foundations. Community support of the Boeing Classic will help increase the rate of discovery in autoimmune disease research and bring the benefits of these discoveries to patients in the Pacific Northwest and around the world.
Donations received during the Boeing Classic will be used to support projects evaluating new therapies for Type 1 diabetes and multiple sclerosis, and to assist with studies of the causes for severe allergy and asthma. Some of the most innovative discoveries that lead to new breakthroughs come from innovative pilot studies made possible by your support. For more information about BRI, or to sign up to receive our e-newsletter, please visit our website at BenaroyaResearch.org.
For More Information